Submitted by Anonymous (not verified) on 21 November 2024 - 12:20
Opinion/decision on a Paediatric investigation plan (PIP): Xerava, eravacycline, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0397/2023
Source: